Monday 17 April | |
Arecor Therapeutics PLC | Full Year Results |
Ashmore Group PLC | Trading Statement |
Diaceutics PLC | Full Year Results |
PageGroup PLC | Trading Statement |
Sirius Real Estate Ltd | Trading Statement |
Surface Transforms PLC | Full Year Results |
Tuesday 18 April | |
ASA International Group PLC | Full Year Results |
Billington Holdings PLC | Full Year Results |
easyJet PLC | Trading Statement |
IntegraFin Holdings PLC | Trading Statement |
LifeSafe Holdings PLC | Full Year Results |
Moneysupermarket.com Group PLC | Trading Statement |
Ninety One PLC and Ltd | Trading Statement |
Petra Diamonds Ltd | Trading Statement |
Property Franchise Group PLC | Full Year Results |
Schroder UK Public Private Trust PLC | Full Year Results |
THG PLC | Full Year Results |
THG PLC | Trading Statement |
Qinetiq Group PLC | Trading Statement |
Xeros Technology Group PLC | Full Year Results |
Wednesday 19 April | |
Antofagasta PLC | Trading Statement |
discoverIE Group PLC | Trading Statement |
Distribution Finance Capital Holdings PLC | Full Year Results |
Entain PLC | Q1 Results |
Liontrust Asset Management PLC | Trading Statement |
Hunting PLC | Trading Statement |
M Winkworth PLC | Full Year Results |
Network International Holdings PLC | Trading Statement |
Quilter PLC | Trading Statement |
Thursday 20 April | |
AJ Bell PLC | Trading Statement |
Centamin PLC | Trading Statement |
Dianomi PLC | Full Year Results |
Dunelm Group PLC | Q3 Results |
Foxtons Group PLC | Trading Statement |
GB Group PLC | Trading Statement |
Hochschild Mining PLC | Full Year Results |
Intelligent Ultrasound Group PLC | Full Year Results |
Oxford BioMedica PLC | Full Year Results |
PensionBee Group PLC | Trading Statement |
Rentokil Initial PLC | Trading Statement |
Rio Tinto PLC | Trading Statement |
Senior PLC | Trading Statement |
Segro PLC | Trading Statement |
WH Smith PLC | Half Year Results |
Friday 21 April | |
Angle PLC | Full Year Results |
BHP Group Ltd | Trading Statement |
Lookers PLC | Full Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
IN BRIEF: Angle presents positive study results for Parasortix
Angle PLC - Surrey, England-based medical diagnostics company - Says proof of concept study shows that both circulating tumour cells and cell-free circulating tumour DNA can be analysed from a single blood sample. "The results show that removal of plasma from blood samples for circulating tumour DNA analysis does not impact on the number or quality of circulating tumour cells which can be successfully isolated from the same sample using the Parsortix system," it explains.
Read more